by EXUMA

Economically Viable, Same-Day Autologous Cell Therapies

In this Q&A, EXUMA's Gregory Frost, Ph.D., and Sid Kerkar, M.D., discuss early experiences with cell therapy, logic gates, and the promise of rapid point-of-care CAR-T therapy.

Link to article